Provider QP97-21 MHCP Pharmacy Benefit Exclusion for Asparlas™, Khapzory™, Nulojix®, Oncaspar® and Susvimo™ Read More
Provider QP101-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective February 1, 2022 Read More
Provider P68R1-21 Update: eviCore Healthcare Specialty Utilization Management (UM) Program - Laboratory Management Clinical Guideline Updates Read More
Provider P69R1-21 Update: eviCore Healthcare Specialty Utilization Management (UM) Program - Cardiology and Radiology Clinical Guideline Updates Read More
Provider P70R1-21 New: eviCore Durable Medical Equipment (DME) Supplementary Guidelines for Medicare Advantage Subscribers Read More
